跳至主要内容
临床试验/NCT07234292
NCT07234292招募中不适用

Evaluation of Patient Satisfaction With a New Preservative-free Eyelid Cream as a Complementary Care in Post-eyelid Surgery: The ADMIRE Study

Laboratoires Thea2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年10月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
global satisfaction of the patient on eyelid comfort after 3 months of Bllephaderm® use, assessed at M4, using a VAS from 0 (unsatisfied) to 10 (very satisfied).

研究概览

简要总结

The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).

The participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old
  • Patients planning a blepharoplasty or a ptosis surgery in at least one eye.
  • Patient affiliated to a health social security system
  • Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.

排除标准

  • In terms of population:
  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Patient who had been deprived of their freedom by administrative or legal decision
  • Minor patient.
  • Major patient who is under guardianship or who is not able to express his non opposition.
  • Patient suspected to be non-compliant according to the investigator's judgment.
  • Patient enrolled in another clinical trial or which exclusion period is not over.
  • In terms of associated pathology
  • Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk.
  • Patient suffering from a severe or progressive disease.
  • Patient with known or suspected hypersensitivity to one of the components of the product.
  • Related to previous or ongoing treatment
  • Patient undergoing a topical treatment on the test area or a systemic treatment.
  • Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation.
  • Patient under immunosuppressive therapy
  • Patient under bisphosphonate therapy
  • Patient having Type 1 diabetes
  • Patient having atopic or eczema skin
  • In terms of lifestyle
  • Intensive exposure to sunlight or UV-rays foreseen during the study.
  • Patient planning to change her/his life habits during the study.
  • Patient with an excessive consumption of alcohol and/or tobacco defined as:
  • an excessive consumption of alcohol: Drinking more than
  • 4 units a day for adult men and more than 2 units a day for adult women,
  • an excessive consumption of tobacco: ≥15-20 Cigarettes Per Day (CPD).

研究组 & 干预措施

Group receiving Blephaderm

干预措施: Cosmetic: Blephaderm (Other)

结局指标

主要结局

global satisfaction of the patient on eyelid comfort after 3 months of Bllephaderm® use, assessed at M4, using a VAS from 0 (unsatisfied) to 10 (very satisfied).

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验